These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 3149839)

  • 1. [The prospects for a study of meningococcal infection caused by serogroup B today].
    Demina AA
    Zh Mikrobiol Epidemiol Immunobiol; 1988 Dec; (12):111-7. PubMed ID: 3149839
    [No Abstract]   [Full Text] [Related]  

  • 2. Serogroup B meningococcal disease: new outbreaks, new strategies.
    Wenger JD
    JAMA; 1999 Apr; 281(16):1541-3. PubMed ID: 10227326
    [No Abstract]   [Full Text] [Related]  

  • 3. ABC of meningococcal diversity.
    Feavers IM
    Nature; 2000 Mar; 404(6777):451-2. PubMed ID: 10761900
    [No Abstract]   [Full Text] [Related]  

  • 4. Neisseria meningitidis serogroup W135 isolates associated with the ET-37 complex.
    Popovic T; Sacchi CT; Reeves MW; Whitney AM; Mayer LW; Noble CA; Ajello GW; Mostashari F; Bendana N; Lingappa J; Hajjeh R; Rosenstein NE
    Emerg Infect Dis; 2000; 6(4):428-9. PubMed ID: 10905984
    [No Abstract]   [Full Text] [Related]  

  • 5. Prospects for vaccine prevention of meningococcal infection.
    Harrison LH
    Clin Microbiol Rev; 2006 Jan; 19(1):142-64. PubMed ID: 16418528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Standardisation and validation of serological assays for the evaluation of immune responses to Neisseria meningitidis serogroup A and C vaccines.
    Jodar L; Cartwright K; Feavers IM
    Biologicals; 2000 Sep; 28(3):193-7. PubMed ID: 10964447
    [No Abstract]   [Full Text] [Related]  

  • 7. No evidence for serosubtype-restricted protection among teenagers vaccinated with the Norwegian group B outer membrane vesicle vaccine.
    Wedege E; Nokleby H; Bjune G
    J Infect Dis; 1999 Jul; 180(1):242; author reply 242-3. PubMed ID: 10353890
    [No Abstract]   [Full Text] [Related]  

  • 8. Assignment of Neisseria meningitidis serogroups A, C, W135, and Y anticapsular total immunoglobulin G (IgG), IgG1, and IgG2 concentrations to reference sera.
    Joseph H; Balmer P; Bybel M; Papa T; Ryall R; Borrow R
    Clin Diagn Lab Immunol; 2004 Jan; 11(1):1-5. PubMed ID: 14715537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional activity of anti-Neisserial surface protein A monoclonal antibodies against strains of Neisseria meningitidis serogroup B.
    Moe GR; Zuno-Mitchell P; Lee SS; Lucas AH; Granoff DM
    Infect Immun; 2001 Jun; 69(6):3762-71. PubMed ID: 11349041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenicity of 2 serogroup B outer-membrane protein meningococcal vaccines: a randomized controlled trial in Chile.
    Tappero JW; Lagos R; Ballesteros AM; Plikaytis B; Williams D; Dykes J; Gheesling LL; Carlone GM; Høiby EA; Holst J; Nøkleby H; Rosenqvist E; Sierra G; Campa C; Sotolongo F; Vega J; Garcia J; Herrera P; Poolman JT; Perkins BA
    JAMA; 1999 Apr; 281(16):1520-7. PubMed ID: 10227322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meningococcal disease, serogroup W135 (update).
    Wkly Epidemiol Rec; 2001 Jul; 76(28):213-4. PubMed ID: 11475872
    [No Abstract]   [Full Text] [Related]  

  • 12. Meningococcal vaccines.
    Poolman JT
    J Med Microbiol; 1988 Jul; 26(3):170-2. PubMed ID: 3134548
    [No Abstract]   [Full Text] [Related]  

  • 13. Molecular mimetics of polysaccharide epitopes as vaccine candidates for prevention of Neisseria meningitidis serogroup B disease.
    Moe GR; Tan S; Granoff DM
    FEMS Immunol Med Microbiol; 1999 Dec; 26(3-4):209-26. PubMed ID: 10575132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meningococcal polysaccharide vaccination of military recruits in Israel: preliminary assessment of vaccine effect.
    Mimouni D; Gdalevich M; Mandel Y; Haim M; Ashkenazi I; Shemer J; Block C
    Scand J Infect Dis; 1998; 30(3):263-4. PubMed ID: 9790134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenicity of two efficacious outer membrane protein-based serogroup B meningococcal vaccines among young adults in Iceland.
    Perkins BA; Jonsdottir K; Briem H; Griffiths E; Plikaytis BD; Hoiby EA; Rosenqvist E; Holst J; Nokleby H; Sotolongo F; Sierra G; Campa HC; Carlone GM; Williams D; Dykes J; Kapczynski D; Tikhomirov E; Wenger JD; Broome CV
    J Infect Dis; 1998 Mar; 177(3):683-91. PubMed ID: 9498448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The worldwide prevention of meningococcal infection. Still an elusive goal.
    Harrison LH
    JAMA; 1995 Feb; 273(5):419-21. PubMed ID: 7823389
    [No Abstract]   [Full Text] [Related]  

  • 17. A case of invasive serogroup C meningococcal disease after a community vaccination programme in Rotherham, South Yorkshire.
    Irwin DJ; Kaczmarski EB; Miller JM
    J Public Health Med; 1998 Mar; 20(1):112-4. PubMed ID: 9602462
    [No Abstract]   [Full Text] [Related]  

  • 18. [Immunoprophylaxis of meningococcal infection among the troops].
    Khokhlov DT; Efimov EI
    Voen Med Zh; 1984 Oct; (10):51-3. PubMed ID: 6438904
    [No Abstract]   [Full Text] [Related]  

  • 19. Evolving meningococcal immunization strategies.
    Sáfadi MA; Bettinger JA; Maturana GM; Enwere G; Borrow R;
    Expert Rev Vaccines; 2015 Apr; 14(4):505-17. PubMed ID: 25494168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Meningococcal Serogroup A, B, C, W, X, and Y Serum Bactericidal Antibody Assays.
    Lucidarme J; Louth J; Townsend-Payne K; Borrow R
    Methods Mol Biol; 2019; 1969():169-179. PubMed ID: 30877677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.